7 ms·
CureVac stops development of COVID19 shot, focusses on new vaccine set for 2022
- charbonneau 5y agoPress release [1]: > CureVac estimates that the earliest potential approval of [first-generation vaccine] would come in the second quarter of 2022. By this time, the companies expect the candidates from the second-generation vaccine program to have progressed to late-stage clinical development. What's the goal of having a COVID vaccine market ready in the third/fourth quarter of 2022? And how will they achieve it? Will it be authorized under an Emergency Use Authorization? Do they anticipate that the circumstances justifying EUA's will continue? [1] https://www.curevac.com/en/2021/10/12/curevac-to-shift-focus-of-covid-19-vaccine-development-to-second-generation-mrna-technology/ https://www.curevac.com/en/2021/10/12/curevac-to-shift-focus...
- the-dude 5y agoFull title : CureVac stops development of its COVID-19 shot, will focus on new COVID-19 vaccine set for 2022